Reaction Details |
| Report a problem with these data |
Target | Potassium channel subfamily K member 2 |
---|
Ligand | BDBM22871 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1584411 (CHEMBL3819954) |
---|
IC50 | 20000±n/a nM |
---|
Citation | Vivier, D; Bennis, K; Lesage, F; Ducki, S Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target? J Med Chem59:5149-57 (2016) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Potassium channel subfamily K member 2 |
---|
Name: | Potassium channel subfamily K member 2 |
Synonyms: | KCNK2 | KCNK2_HUMAN | Outward rectifying potassium channel protein TREK-1 | TREK | TREK-1 K(+) channel subunit | TREK1 | Twik-RElated Potassium (K+) channel 1 (TREK1) | Two pore domain potassium channel TREK-1 | Two pore potassium channel TPKC1 |
Type: | Protein |
Mol. Mass.: | 47099.16 |
Organism: | Homo sapiens (Human) |
Description: | O95069 |
Residue: | 426 |
Sequence: | MLPSASRERPGYRAGVAAPDLLDPKSAAQNSKPRLSFSTKPTVLASRVESDTTINVMKWK
TVSTIFLVVVLYLIIGATVFKALEQPHEISQRTTIVIQKQTFISQHSCVNSTELDELIQQ
IVAAINAGIIPLGNTSNQISHWDLGSSFFFAGTVITTIGFGNISPRTEGGKIFCIIYALL
GIPLFGFLLAGVGDQLGTIFGKGIAKVEDTFIKWNVSQTKIRIISTIIFILFGCVLFVAL
PAIIFKHIEGWSALDAIYFVVITLTTIGFGDYVAGGSDIEYLDFYKPVVWFWILVGLAYF
AAVLSMIGDWLRVISKKTKEEVGEFRAHAAEWTANVTAEFKETRRRLSVEIYDKFQRATS
IKRKLSAELAGNHNQELTPCRRTLSVNHLTSERDVLPPLLKTESIYLNGLTPHCAGEEIA
VIENIK
|
|
|
BDBM22871 |
---|
n/a |
---|
Name | BDBM22871 |
Synonyms: | 13-chloro-10-(4-methylpiperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,9,12,14-heptaene | 2-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine | 8-chloro-6-(4-methylpiperazino)benzo[b][1,4]benzoxazepine;succinic acid | CHEMBL831 | CL71,563 | Cloxazepine | Loxapine |
Type | Small organic molecule |
Emp. Form. | C18H18ClN3O |
Mol. Mass. | 327.808 |
SMILES | CN1CCN(CC1)C1=Nc2ccccc2Oc2ccc(Cl)cc12 |t:8| |
Structure |
|